Payment overview · 2025
General Payments
$36.42
2 reported records · 2 companies
Healthcare provider profile · identity verified
Gene Dewayne Adams, PA
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant · COOKEVILLE, TN · NPI 1508961301
Verified facts
What the public records show
CMS Open Payments records show Gene Dewayne Adams, PA received $36.42 in general payments during 2025 across 2 reported records.
Gilead Sciences, Inc. accounted for 60.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | Unresolved — no canonical attribution shown | $22.13 | 60.8% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $14.29 | 39.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $36.42 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Repatha Normalized: repatha |
Biological | Amgen Inc. | $14.29 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 408 | 185 |
| Lisinopril | Lisinopril | 307 | 140 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 254 | 95 |
| Losartan Potassium | Losartan Potassium | 236 | 89 |
| Levothyroxine Sodium | Levothyroxine Sodium | 233 | 101 |
| Omeprazole | Omeprazole | 233 | 109 |
| Amlodipine Besylate | Amlodipine Besylate | 232 | 113 |
| Gabapentin | Gabapentin | 228 | 75 |
| Metformin Hcl | Metformin Hcl | 192 | 86 |
| Furosemide | Furosemide | 183 | 83 |
| Pantoprazole Sodium | Pantoprazole Sodium | 173 | 82 |
| Metoprolol Tartrate | Metoprolol Tartrate | 129 | 52 |
| Montelukast Sodium | Montelukast Sodium | 124 | 52 |
| Meloxicam | Meloxicam | 122 | 61 |
| Hydrochlorothiazide | Hydrochlorothiazide | 117 | 61 |
| Potassium Chloride | Potassium Chloride | 117 | 59 |
| Clopidogrel | Clopidogrel Bisulfate | 112 | 42 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 106 | 54 |
| Trazodone Hcl | Trazodone Hcl | 101 | 48 |
| Famotidine | Famotidine | 100 | 40 |
| Carvedilol | Carvedilol | 97 | 48 |
| Tamsulosin Hcl | Tamsulosin Hcl | 93 | 47 |
| Metoprolol Succinate | Metoprolol Succinate | 90 | 48 |
| Eliquis | Apixaban | 87 | 35 |
| Glimepiride | Glimepiride | 87 | 45 |
| Fluticasone Propionate | Fluticasone Propionate | 84 | 43 |
| Buspirone Hcl | Buspirone Hcl | 68 | 29 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 68 | 33 |
| Allopurinol | Allopurinol | 65 | 32 |
| Sertraline Hcl | Sertraline Hcl | 65 | 27 |
| Ropinirole Hcl | Ropinirole Hcl | 64 | 18 |
| Metformin Hcl Er | Metformin Hcl | 62 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 59 | 22 |
| Prednisone | Prednisone | 58 | 46 |
| Spironolactone | Spironolactone | 57 | 28 |
| Tizanidine Hcl | Tizanidine Hcl | 57 | 24 |
| Duloxetine Hcl | Duloxetine Hcl | 54 | 25 |
| Ozempic | Semaglutide | 54 | 19 |
| Ondansetron Odt | Ondansetron | 53 | 27 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 52 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 51 | 21 |
| Pravastatin Sodium | Pravastatin Sodium | 51 | 24 |
| Alendronate Sodium | Alendronate Sodium | 49 | 19 |
| Fenofibrate | Fenofibrate | 49 | 26 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 48 | 20 |
| Azithromycin | Azithromycin | 46 | 40 |
| Trulicity | Dulaglutide | 46 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 45 | 20 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | 17 |
| Ezetimibe | Ezetimibe | 43 | 26 |
| Citalopram Hbr | Citalopram Hydrobromide | 42 | 21 |
| Atenolol | Atenolol | 40 | 17 |
| Donepezil Hcl | Donepezil Hcl | 40 | 19 |
| Simvastatin | Simvastatin | 40 | 19 |
| Celecoxib | Celecoxib | 38 | 11 |
| Cefdinir | Cefdinir | 37 | 35 |
| Glipizide | Glipizide | 37 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 37 | 18 |
| Oxybutynin Chloride | Oxybutynin Chloride | 37 | 16 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 36 | 20 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 36 | 31 |
| Fluoxetine Hcl | Fluoxetine Hcl | 35 | 17 |
| Lovastatin | Lovastatin | 33 | 15 |
| Pregabalin | Pregabalin | 33 | 14 |
| Mirtazapine | Mirtazapine | 32 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 32 | 14 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 32 | suppressed |
| Jardiance | Empagliflozin | 31 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 31 | 14 |
| Baclofen | Baclofen | 30 | 12 |
| Promethazine Hcl | Promethazine Hcl | 30 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 29 | 19 |
| Januvia | Sitagliptin Phosphate | 29 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 28 | 17 |
| Paroxetine Hcl | Paroxetine Hcl | 27 | suppressed |
| Alprazolam | Alprazolam | 25 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 25 | suppressed |
| Fluconazole | Fluconazole | 25 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 25 | 12 |
| Mounjaro | Tirzepatide | 25 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 24 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 24 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 24 | 11 |
| Benazepril Hcl | Benazepril Hcl | 22 | 14 |
| Clonidine Hcl | Clonidine Hcl | 22 | 16 |
| Ibuprofen | Ibuprofen | 22 | 15 |
| Linzess | Linaclotide | 22 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 22 | 11 |
| Meclizine Hcl | Meclizine Hcl | 22 | 16 |
| Synthroid | Levothyroxine Sodium | 22 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 22 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 22 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 21 | suppressed |
| Nifedipine Er | Nifedipine | 21 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 21 | suppressed |
| Memantine Hcl | Memantine Hcl | 20 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 20 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 20 | 14 |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 18 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | 17 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Mupirocin | Mupirocin | 17 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 17 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 17 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 16 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Gemfibrozil | Gemfibrozil | 16 | suppressed |
| Nitroglycerin | Nitroglycerin | 16 | 13 |
| Topiramate | Topiramate | 16 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 15 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Xarelto | Rivaroxaban | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Finasteride | Finasteride | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 13 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 13 | suppressed |
| Clonazepam | Clonazepam | 12 | suppressed |
| Diazepam | Diazepam | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Lubiprostone | Lubiprostone | 12 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 12 | 12 |
| Sildenafil Citrate | Sildenafil Citrate | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Sure Comfort Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | 11 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $36.42 · 2 records | Gilead Sciences, Inc. | Repatha | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error